AlphAIalphai — Financial news for AI agents
ocbj.comJUL 292 min read

Vestand, Formerly Yoshiharu, Delisted from Nasdaq

Nasdaq delisted Vestand Inc., formerly Yoshiharu Ramen, on July 27, according to a July 28 regulatory filing. The company’s shares fell to about $0.02 on Monday and it began trading on the OTC Pink Limited Market. Nasdaq cited prolonged disclosure absences and business changes, plus concerns about experience and stability. Vestand missed requirements including a $1 minimum price and timely quarterly and annual filings.

Original reporting
ocbj.com
Published Jul 29, 2026, 1:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 1:28 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Vestand, Formerly Yoshiharu, Delisted from Nasdaq — source image
Source · ocbj.com
Decision brief

The 30-second read

Med
01

Why it matters

Nasdaq’s delisting decision, tied to disclosure lapses and failure to meet minimum price and reporting requirements, increases liquidity and compliance risk and can reduce institutional participation.

02

Market read

Traders should reassess liquidity, spread, and downside risk after the exchange downgrade and the stated compliance failures.

03

What to watch

The article does not quantify the likelihood/timeline of reinstatement, nor does it detail any financing or restructuring plans that could materially change survival odds.

Relevance 6/10Novelty 6/10Timing: after-hours/next-session impact from July 27 Nasdaq delisting and July 28 filing rationale

Background

Vestand Inc., formerly Yoshiharu Ramen, went public in 2022 and began trading on the OTC Pink Limited Market the same day as the Nasdaq delisting.

Market effects

Sector

Adds to the microcap delisting risk narrative, potentially raising perceived compliance risk premia across similar OTC-to-Nasdaq issuers.

Regional

Primarily US microcap liquidity and exchange-structure impact.

Global

Limited beyond US small-cap/OTC investor base.

Counterpoint

What could challenge this read

If Vestand can quickly cure reporting deficiencies and regain compliance, the OTC period could be a temporary dislocation rather than a permanent impairment.

Key entities

  • regulator
    Nasdaq Hearings Panel

    Cited prolonged absence of public disclosure and reservations about experience and institutional stability for the delisting decision.

  • issuer
    Vestand Inc.

    Ramen chain that pivoted in 2025 to real estate development and digital asset ventures; failed Nasdaq listing requirements and was delisted.

Read at source← All news

Related articles

MAY 26
$VSTDHighAI 9/10

Vestand Receives Nasdaq Staff Determination Notification Regarding Late 10-Q and 10-K Filings and Continued Listing Requirements

Vestand Inc. (NASDAQ: VSTD) said Nasdaq issued a May 19, 2026 staff delisting determination after the company failed to file Form 10-Qs for Sept. 30, 2025 and March 31, 2026 and Form 10-K for Dec. 31, 2025. Nasdaq initiated a delisting process, but it has no immediate effect. Vestand filed a May 22 hearing request to appeal and seek a stay while it prepares the delinquent reports.

manilatimes.net2 min
AUG 9
$000660.KSMed

SK Hynix to mull options for US$3bn China plant

Bloomberg reports SK Hynix is reviewing options for its Chongqing, China semiconductor packaging and testing plant, including possibly bringing in an investor or selling a stake that could value the facility at about US$3 billion, according to people familiar with the matter. Separately, SK Hynix plans a 54 trillion won (US$38 billion) South Korea expansion for DRAM and NAND, citing AI-era memory demand.

taipeitimes.com5 min
AUG 9
$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

yahoo.com6 min
AUG 9
$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

rttnews.com2 min
AUG 9
$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

rte.ie6 min